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1
INTRODUCTION
Microbiota
Microbiota or microbial flora is “the microscopic living organisms of a region”
(1). It locates in the human gastrointestinal tract and has an effect on our health and
well-being. Microbiota has significant influence role in host metabolism and also
helps supplies a natural defense mechanism barrier against invading pathogens.
Different bacterial groups are found throughout the gastrointestinal tract from mouth
to colon in various amounts.
In the human digestive tract, the population of microflora is a very complex but
rather stable ecological community (2).

The human GI tract is populated by an

excess of 1010 bacterial cells per gram, at least 1012 living bacterial cells in the entire
colon (3), that make up from at least 500 different bacterial species (4). In the large
intestine, bacteria such as Bacteroides, Bifidobacterium, Eubacterium, Clostridium,
Fusobacterium and Ruminococcus are usually found. Inflammatory bowel disease
or the use of antibiotics can affect the defense mechanisms provided by the
intestine’s bacterial community. For this reason many foods are scientifically
intended to help strengthen the gut’s defense system. These ‘functional foods’ work
by adding probiotic organisms and claim to have a health benefit above basic
nutritional value. Functional Foods were first developed in 1980s in Japan (5).

Aging
The composition of the gastrointestinal (GI) microflora changes with the
increased age of the host (6). This is mainly due to alterations in dietary habits and
in GI physiology. Aging, for instance, is associated with decreased consumption of
fiber, since fiber-rich foods tend to require more mastication than other foods (7, 8).
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In addition, diet composition could be altered due to the decline in olfactory and
gustatory sensitivity (9), and the decrease in cognition (10) which is sometimes
brought on by aging. Moreover, the aging GI tract commonly undergoes
pathophysiological processes leading to conditions such as gastric hypochlorhydria,
intestinal dysmotility, and decreased colonic transit time (11). These conditions may
promote the preferential growth of specific bacterial colonies, thereby altering the
composition of the GI microbiota, which in turn affects intestinal homeostasis and
function (12). Additionally, the pathophysiological changes seem to effect the
regulation of essential groups of the gastrointestinal bacterial flora (13). An animal
feeding study showed that the population of guts bacteria depends largely on age of
animal, even with adding synbiotics into the diet (13). One important consequence
of the changes associated with aging is the decrease in the number and diversity of
beneficial microbiota in elderly humans (14) and in older animals (15).

Beneficial-Probiotic
According to the FAO/WHO, probiotics are live microorganisms that are
similar to beneficial microorganisms found in the human gut, when given in adequate
amounts grant a health benefit on the host. This word came from pro ("for") in Latin
and βιωτικός (biotic) in Greek, the latter deriving from the noun βίος (bios, "life") (16).
Probiotics are found in fermented dairy products such as yogurt and kefir. It also is in
granola bars, soy products and dietary supplements. Lactic acid bacteria (LAB) and
Bifidobacterium are the most common types of microbes used as probiotics.
Probiotics aid in preventing and treating a wide variety of diseases, from acute
gastroenteritis

to

intestinal

neoplasia

(17).

According

to

the

American
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Gastroenterological Association, research shows that probiotics help boost immune
system, prevent infection, strengthen the barrier of the intestine and inhibit or destroy
toxins. The studies also show that probiotics also relieve the symptoms of irritable
bowel syndrome symptoms like constipation, diarrhea, abdominal cramps and other
disorders.
To grant a significant health benefit, the ideal probiotic should be resistant to
gastric acid digestion, to bile salts, and remain viable in the intestine in order to have
greater immunologic effects and should be able to adhere to the intestinal epithelium
wall (18, 19).
Some microbiotas are derived from the human intestine while others are
nonhuman strains used in the fermentation of dairy products. Most probiotics are
strains of Bifidobacterium or the Lactobacillus species. Some other bacteria like
Streptococcus, Bacillus, and Enterococcus were also used but there are less prefer
since the might contain some pathogen like Enterococcus (20). Yeasts such as
Saccharomyces genus are also known for probiotics properties.
Research shows that probiotics have also managed the symptoms of
diarrheal diseases. Statistically, the prevention of antibiotic-associated diarrhea
could be done by supply the mixture of yeast Saccharomyces boulardii and the
bacterium Lactobacillus acidophilus combined with L. bulgaricus, L. rhamnosus
strain GG [American Type Culture Collection (ATCC) 53103; LGG], and
Enterococcus faecium strain SF68. These help to reduce the length of diarrhea by
>30 h (21).
Another research study has shown the effect of a probiotic mix (containing 3 ×
1011 CFU L. bulgaricus, L. casei, L. plantarum, L. acidophilus, Bifidobacterium
longum, B. breve, B. infantis, and S. thermophilus) preventing flares of chronic
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pouchitis in patients with inflammatory bowel disease (22) and that by using of a
different probiotic mix [B. lactis Bb12 and Lactobacillus reuteri (ATCC 55730) at 1 ×
107 CFU/g in a cow milk formula] could prohibit diarrheal in infants attending
childcare (23).
Even

though

probiotic

mostly

have

the

major

clinical

effects

on

gastrointestinal disorder, but some were shown to effect non-gastrointestinal
diseases such as the treatment and prevention of atopic eczema (24).
Lactobacilli and Bifidobacterium represent two important groups of probiotic
bacteria in intestinal micro flora. They have unique properties which provide the
benefits to the host body in several ways.

Bifidobacterium
Bifidobacterium is gram-positive, anaerobic, nonmotile, nonsporeforming rods
of variable appearance somewhat irregular or branched rod shaped bacteria.
Bifidobacterium has a hexose metabolism through a phosphoketolase pathway or
bifid shunt, and uses the key enzyme frutose-6-phosphate phosphoketolase
(F6PPK). It is generally used as a diagnostic test for this Bifidobacterium as it is not
found in other gram-positive intestinal bacteria. Bifidobacterium is to “commensal
relationship” in human–microbe interactions. In newborn infants, colonization inside
gastrointestinal tract begins the moment after birth (25). Mode of delivery, initial diet,
geographical location and type of delivery dictate the colonization pattern (26).
Generally, Bifidobacterium infantis, B. brevi, and B. longum are the largest group of
bacteria in the intestine of infants. The number of Bifidobacterium remains relatively
stable representing 3–6% of the fecal flora and started to decline in advanced age
(27). Bifidobacterium occupy a large percentage compared to other microflora in the
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gastrointestinal region, said to be the 3rd or 4th largest group in adults because they
can use many source of molecule for energy (28). For example, B. longum genome
codes for variety of enzymes that use for catabolism of oligosaccharides,
nondigestible fiber, host-derived glycoproteins and glycoconjugates (29).
The different species of Bifidobacterium have seen a great increase in
commercial and consequent scientific interest in lately, due to the ability to relive
many types of disorders.
Antibiotics have an effect on the intestinal microflora community by
decreasing the ability to colonize and promoting the growth of putrefactive microbes
like Clostridium and Klebsiella species. Bifidobacterium, such as B. longum, has
shown to reduce the incidence and duration of antibiotic-associated diarrhea (30,
31).
Research shows that the traveler’s diarrhea incident can be reduce by using
the combination of Bifidobacterium and other probiotic strains from 71 to 43% in
tourists travelling to Egypt by given capsules of S. thermophilus, Lactobacillus
bulgarius, Lactobacillus acidophilus and B. bifidum (32).
Research also shows that Bifidobacterium has anti-inflammatory capacity in
vitro by inhibiting LPS-induced NF-κB activation (33). Further research also shows
that Bifidobacterium has therapeutic effects in allergy and inflammatory disorders by
activating MAPK, GSK3 and PI3K in order to modulate DC biological functions (34).
For individual who suffer lactose intolerance, Bifidobacterium longum was
shown to have a potential probiotic treatment effect on the relieving of the symptoms
(35).
The population of Bifidobacterium is high in infants and starts decline with
age. Hence, infants intestinal microflora have the antagonistic activities and ability to
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resist certain enteric infections and work more effectively compared to adults with a
lower count of indigenous Bifidobacterium using the mechanism such as the
production of various acids, hydrogen peroxide or bacteriocins, the competition for
nutrients or adhesion receptors, anti-toxin action and stimulation of the immune
system (36). With age, Bifidobacterium population is inversely proportional to the
number of Clostridium perfringens detected in the elderly (37).
After lung cancer in men and breast cancer in women, colorectal cancer is the
second most common cancer in Europe via epidemiological study data.

Indirect

result of some studies show that probiotic microflora help prevent, or delay the onset
of certain cancers. The reason is the increasing levels of putrefactive microbes and a
decrease in the levels of Bifidobacterium that cause by a diet high in meat and fat
but low in fiber (38). The fecal enzymes such as beta-glucuronidase, azoreductase,
urease and nitroreductase convert procarcinogens into carcinogens and may be a
factor on an increased risk for colorectal cancer (39). Bifidobacterium‘s conjugated
linoleic acid production is also believed to yield anticarcinogenic effects (40).
Bifidobacterium longum and B. breve are believed to help prevent DNA damage by
carcinogens (41). Bifidobacterium longum has also been recognized as aiding the
reduction of aberrant crypt foci (ACF) occurrence in rats (42), which induce the antitumor activity.
A mixture of four Lactobacillus strains, three Bifidobacterium species (B.
breve, B. infantis, B. longum) and a Streptococcus thermophilus strain have shown
to have an effect on therapeutic and prophylaxis of inflammatory bowel syndrome
(IBD) (43). IBD, a disruption in bowel habits and mucosal inflammation, is the
overlapping phenotypes of Crohn’s disease and ulcerative colitis. The causes are
still unclear but could be due to the genetic disposition and intestinal microflora.
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There is evidence to suggest that the IBD symptom could be alleviated by the
modification of the composition of microflora (44).The mechanism, still under
investigation, could be the mucosa‘s cytokine transcription factors and regulation
response to invasive microbes as well as interaction with mucosal regulatory T cells
(45).
Another health benefit related to Bifidobacterium is the prevention and relief of
constipation, especially in elderly. Probiotics have also been used to enhance the
growth of Bifidobacterium in large intestine and have been found to have laxative
effect (46). In another study, B. bifidum was shown to have the ability to relieve
severe premenstrual syndrome (PMS) in relation to the gastrointestinal symptoms
such as constipation, diarrhea and abdominal pain (47).
Since another duty of GI tract, beside absorption and digestion, are the
defense barrier against antigens from microorganism and food, and then we can
assume that probiotic is directly impacting the host’s immunity function. For example,
B. lactis can induce the natural immune function by dietary consumption (48) and B.
bifidum also shows the possibility to increase the immunomodulation effect in
combination with other probiotic strains when consumed in cheese (49). B. infantis
show an immunoregulatory role in the repression of Th2 cytokines during antigen
sensitization (50).
Lastly, probiotic Bifidobacterium shows some evidence that it might assist on
reducing the serum cholesterol that would lead to lower chances of cardiovascular
disease (51). Probiotic intake increases the production of the enzyme bile salt
hydrolase which shows decrease the serum cholesterol levels (52).
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Lactobacillus
Lactobacillus is a gram-positive facultative anaerobic (microaerophilic), rodshaped bacteria. They are the primary of the lactic acid bacteria group, which
converts lactose and other sugars to lactic acid. In humans, they are present as a
small group of gut flora and also found in vagina (53). Lactobacillus produces lactic
acid, which also lowers the pH of the fermenting substance that is used in food
productions such as yogurt, cheese, pickled, and starter culture for sourdough. In
beer production, L. casei and L. brevis are commonly used as a beer spoilage
organism.
According to the Beth Israel Deaconess Medical Center and UCLA in 2009,
They believed that some strains of Lactobacillus spp. and other lactic acid bacteria
can help prevent tumor and cancer especially a colonic tumors (54).
A mixture of Lactobacillus species, Enterococcus species, and S. boulardii
were shown to improve the infective diarrhea in both adults and children (55).
Other benefits by oral administration are shown to decreased the chance of
DNA adducts formation, ameliorated DNA damage and prevented putative
preneoplastic lesions such as aberrant crypt foci in the gastrointestinal tract (56).
Lactobacilli is believed to help improve the gut micro flora and combat against
unwanted bacteria with regular consumption, for example the production of natural
agent “bulgarican” from L. acidophilus and L. bulgaricus .Bulgarican help fight
against the spreading of other unwanted bacteria species in foods and in the human
gut. Active Lactobacilli micro-flora has ability to alter the pH by producing lactic acid
in large intestine, as a result, these created the uninhabitable environment for
spoilage bacteria. It also helps destroyed other undesirable microbe like moulds,
mould spores and yeast, especially Candida form. Lactobacilli can also be used to
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restore physiological balance of the vaginal and helps protect the ecosystem from
other bacterial infection (56).
Other benefits of Lactobacillus is the production of enzymes which when
exposed to food, help break down the structure of that substance so the nutrients are
easy to absorb by human digestive system and often increase the biological value of
foods. The enzyme activity also benefits greatly in aged population where digestive
efficiency tends to weaken when age progress (56).

Gram positive bacteria cell wall

The gram-positive cell wall consists of tough mesh, several rows and layer of
peptidoglycan and teichoic acid, cross linked with lipoteichoic acid molecule and
surface proteins. These structures provide strength and rigidity while maintaining
elasticity and flexibility to offset intracellular turgor pressure associated with the
maintaining of cell shape and preventing against osmotic lysis.
Peptidoglycan, made 60-90% of the cell wall structure and thicker in gram
positive bacteria, is made of rigid glycan chains of N-acetylglucosamine (GlcNAc)
and N-acetylemuramic acid (MurNAc), connected by b-1, 4 glycosidic bonds and
cross linked by flexible peptide bridge making a glycan numerous interconnecting
layer 20-80 nm thick (57).
Teichoic acid, which is a unique gram positive bacteria cell wall, is a polyribitol
phosphate and glycerol phosphate, cross linked to peptide glycan making the outer
layer. Teichoic acid attaches the cations, like magnesium and sodium, in order to
maintain the stability and rigidity for the bacteria cell wall.
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Lipoteichoic acid, cytoplasmic membrane lipids, works as a lipid link to the
teichoic acid. These substances are combined to form the covalent multilayered
structure.
Even though peptidoglycan presents in both gram positive and gram negative
bacteria cell wall, gram positive cell wall contain more in quantity, chain length, the
degree of cross link and the thickness (58). The lyses of a strong peptidoglycan
barrier pose a challenge to overcome in order to disrupt the cell wall (59).
Other characteristics of the gram positive bacteria cell wall that interfere with
the lysis process are; The petidoglycan layer are thick and abundant, and also
contain many cross-linked 50 nm wind glycan strands that provided even more
strength. Second, the covalent bond of the teichoic acid to the lipoteichoic acids
causes interwoven in the cell wall. Third, each strain and species of the bacterium
are different depending on the type of surface protein on the outer layer of
peptidoglycan. Lastly, the viscous material that is presents in the periplasm region
between the peptidoglycan layer and cytoplasmic membrane helps provide another
barrier for the cell (60).
Microbiota development and characterization in the human host still rests
largely on culture-dependent methods (11). These conventional methods have
many drawbacks. First, their sensitivity is rather low. Second, they are quite time
consuming and therefore not very cost-effective. Third, a cultural method requires
the use of a fresh sample and to perform operations after sampling. Some might be
limited to a difficult condition, like anaerobic culturing, while PCR is not. Next, PCR
sample can be preserved in the freezer and transported in the distant future. Forth
and most importantly, since only certain bacterial species and strains are amenable
to culture, the results could be biased (certain bacterial populations might be
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overestimated, while others might be missed). Thus, during the last decade,
developments in molecular biology have led to the application of fast and reliable
alternative culture-independent methods (61).

For instance, in one study by De

Vrese et al., quantitative real time PCR was utilized to estimate the levels of certain
bacterial populations in the intestines of mice (62).
The aim of this study was to establish a method to detect the gastrointestinal
tract microbiota, either by fecal or colonic tissue DNA extraction.
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Figure1: Adhesins in the bacterial cell wall bind to receptor molecules on the surface
of a susceptible host cell.
Copyright © Gary E. Kaiser All Rights Reserved Updated: January 30, 2001

Figure2: The Gram-positive cell wall appears as dense layer typically composed of
numerous rows of peptidoglycan, and molecules of lipoteichoic acid, wall teichoic
acid and surface proteins.
Copyright © Gary E. Kaiser, The community College of Baltimore County, Catonsville Campus:
January 27, 2001
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MATERIALS AND METHODS
Mice
C57BL/6, specific pathogen-free male and female mice were used. The caring
of the animals was in accordance with the NIH guidelines for the use and care of
laboratory animals, and the animal protocol was approved by the Institutional Animal
Care and Use Committee of the Wayne State University Animal Investigation
Committee. Animals were housed, two mice per cage and kept in a 12-hour darklight cycle, controlled environmental temperature of 22 + 2oC. Animals had free
access to distilled water at all times. The amount of food provided was ad libitum.
Food consumption and physical activity change were monitored daily.

Fecal sample collection
Fresh fecal samples were obtained from mice between the ages of 3 months
to 1 year old. For collection, the mice were transferred to a cage that contains a onecentimeter-wired-mesh grating floor for one hour. To prevent the integration of feces
and urine, the paper towel was used as a lining on the bottom of the cage for
absorption. The mesh allows for collection of fresh feces to avoid mixing with older
feces from cages and to avoid contamination from bedding material. Moreover, this
can also prevent the autocoprophagy. The feces were then collected and stored at 20oC until further analysis.

Colonic tissue sample collection
Mice were euthanized via cervical dislocation method. They were then
aseptically dissected and colon tissue was removed. The feces inside the intestine
were collected for DNA extraction. The colon was rinsed and washed from the inside
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out of the intestine using forceps and syringe (20G) with PBS solution (Fisher
Scientific Inc. Fairlawn, New Jersey).
The colon was collected using several different methods to assess the optimal
and the best form of tissue collection for bacteria quantization. First, we transferred
the colon tissue directly to a 15 ml tube containing 2 ml of DNAzol direct solution,
manually homogenized then incubated at 95oC for 15minute, homogenized, vertex
and spun down.
Second, we rinsed the intestine with PBS buffer and the tissue was
transferred onto a microscope slide on ice. The intestine was cut open by using two
forceps holding one end of the intestine with angled serrated forceps and squeezing
out the epithelial cells with the other forceps by running the smooth-edged forceps
slowly to the other end of the tube. The epithelia cells were suspended in 1 ml of
DNAzol direct solution. The rest of colon muscularis was also transferred into 2 ml of
DNAzol direct solution. We then continued with the rest of the extraction protocol
using the same process as the first condition.

Strain culture

In order to generate a positive control for Bifidobacterium experiments, we
purchased DNA of B. adolescentis cat#15703D, B. breve cat#15700D-5 and B.
infantis from ATCC (Manassas, VA). In addition, we grew a culture of
Bifidobacterium breve; ATCC#15701- freeze-dried culture, which also was obtained
from ATCC. Aseptically rehydration and inoculation of the culture was made using
Difcoreinforced Clostridial medium (Becton, Dickinson and Company. Franklin
Lakes, NJ). Inoculum broth was incubated at 37°C for 24 hours under anaerobic
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conditions generated using the GasPak EZ anaerobe container system (Becton,
Dickinson and Company. Franklin Lakes, NJ).Then the bacteria were cultured on
agar plates using the same media and conditions. This provided a means for the
evaluating PCR primer and DNA extraction method efficiency.

DNA extraction

DNA was extracted from feces for PCR detection. In addition DNA was
extracted from entire colon and colonic scraping for PCR detection as well.

ZR Fecal DNA kit (ZYMO RESEARCH CORP. Orange, CA Catalog no.D6010)
The protocol was adapted from the manufacturer’s instruction manual. The
principle of this method was to lyses and centrifuged using ultra-high density beads
that is fracture resistant and chemically inert.
We added up to 75 mg of fecal sample to a lysis tube, and then filled with 750

ul lysis buffer to the tube. Vertex for 10 minutes. Centrifuged the lysis tube in a micro
centrifuge at ≥10,000 x g for 1 minute. Transferred up to 400 ul supernatant to a spin
filter in a collection tube and centrifuged at 7,000 rpm (~7,000 xg) for 1 minute,
added 1,200 ul of fecal DNA binding buffer to the filtrate. Then transferred 800 ul of
the mixture to a column in a collection tube and centrifuged at 10,000 xg for 1
minute. Discarded the flow through from the collection tube and repeated the
centrifuge for another 1 minute. Added 200 ul DNA pre-wash buffers to the column in
a new collection tube and centrifuged at 10,000 xg for 1 minute. After that, added
500 ul fecal DNA wash buffer to the column and centrifuged at 10,000 xg for 1
minute. Transferred column to a clean 1.5 ml micro centrifuge tube and added 100 ul
(25 ul minimum) DNA Elution Buffer directly to the column matrix, centrifuged at
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10,000 xg for 30 seconds to elude the DNA. Transferred the eluted DNA to a spin
filter in a clean 1.5 ml micro centrifuge tube and centrifuged at exactly 8,000 xg for 1
minute. DNA extracted was stored at -20°C until its use.

DNAzol Direct (Molecular Research Center, Inc. Cincinnati, OH)
In addition to ZR fecal kit, we also utilized DNAzol to determine which method
gave the best quality DNA.
DNAzol direct is the reagent that was used for processing biological samples
for the direct PCR, using alkaline solution containing polyethylene glycol and other
additive to lyse the sample and releasing the DNA into the lysate. The combined
effects of the alkaline pH and chaotropic properties induce the inactivation of PCR
inhibitor such as protease and nucleic acid degradation enzyme.
To extract, we mixed up approximate 1-10 mg of fecal sample with 0.1 ml
Nuclease-free water (Thermo Fisher Scientific Inc. Pittsburgh, PA). Handhomogenized until mixed well then we added 0.1 ml of DNAzol Direct. To ensure the
maximum yield, we incubated the mixture at 95 °C using heating block for 15
minutes. Vortexes the lysate for 30 seconds and transferred a 2 ul aliquot directly
into the PCR mix, or froze at -20 °C until use.
For the bacteria colony, we picked one colony then mixed directly into 0.1 ml
of DNAzol Directed and continued to incubation as explained above.

Quantitative reading of DNA/RNA
The quantitative of DNA/RNA were measured using The Thermo Scientific
NanoDrop (series) spectrophotometer. The spectrophotometer measurement and
the absorbance of the total molecule in the sample of interest, each wave length
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represent different molecule; 230 indicates the presence of organic compound
contaminants i.e. carbohydrates, phenol and EDTA. A260 shows the total of
nucleotides, RNA, ssDNA, and dsDNA. While A280 exhibits the concentration of
proteins content. The ratios of each value indicate the quality of sample:
260/280 ratio indicates the purity of DNA and RNA. A ratio of ~1.8 is generally
accepted as “pure” for DNA while a ratio of ~2.0 is generally accepted as “pure” for
RNA. If the ratio is lower in either case, it may indicate the presence of contaminants
that absorb, at or near, 280 nm i.e. protein, phenol or other.
260/230 ratio is used as a secondary measure of nucleic acid purity. The 260/230
values for “pure” nucleic acid are often higher than the respective 260/280 values,
commonly in the range of 2.0-2.2. If lower, then it may indicate the presence of
contaminants, which absorb at 230 nm.
The procedure, according to the manufacturer’s manual, combines with the
use of software program. Nuclease free water was used as standard blank sample,
and for cleaning during each sample measurement. With the arm open, pipette 2 ul
of sample directly onto pedestal. The pedestal automatically adjusted for an optimal
path length (0.05 mm - 1 mm). When the measurement is complete, the surfaces are
simply wiped with lint-free lab wipe and nuclease free water before measuring the
next sample. Nucleic acid samples required purification prior to measurement.

RNase treatment
To determine zero contamination of RNA in the DNA extraction, we performed
RNase treatment using RNase enzyme (QIAGEN Inc. Valencia, CA). The RNase
was mixed into DNA extraction at the ratio of RNase: DNA=1:10. This was incubated
on heating block for 30 minutes at 37°C then another 10 minutes at 70°C to denature
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the enzyme and stop the treatment process. The product was being purified using
QIAquick PCR Purification kit, the protocol as describe in the cloning and
sequencing section, and was used to get rid of the excess enzyme. The product
was kept on ice until further use.

Primers
After searching through multiple publications, PCR primers were chosen, as
listed on Table 1. These primers were designed to target the 16s rRNA region of
different members of Bifidobaterium species and Lactobacillus species. All of the
oligonucleotides used were purchased from Invitrogen Corporation (Carlsbad, CA).
All primers were tested for the primer concentration optimization. The higher primer
concentration can increase the efficiency of PCR but can also lead to primer dimmer
formation. The concentrations of each primer was adjusted by diluting with nuclease
free water and mixed into 25 uL of total PCR reaction to reach the final concentration
of 1.9, 1.0, 0.5, 0.1 and 0.05 uM. The 0.1uM final concentrations yielded the best
results for amplifying of target DNA without primer dimmer formation in negative
control or showed no evidence of secondary priming.
The specificity of primers were tested by amplifying DNA from the target
organism purchased from ATCC which were diluted into 1:10 dilution by nuclease
free water and used as positive control throughout the experiment.

Qualitative PCR
PCR
The experiment started off with normal PCR. The mixture of the PCR
mastermix of 10.1 ul of nuclease free water, 2 ul 10x PCR buffer 10x, 0.8 ul of 2.5
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mM dNTP mix, 0.4 ul each of 25 uM working concentration forward and reverse
primer and 1.25 ul of MgCl2 and 0.1 ul of Taq polymerase were mixed with 5 ul of
DNA template then put in the thermocycler set the cycle parameter at (i) 2 minutes
at 95°C 1 cycle then (ii) 30 cycles of 30 seconds at 95°C, 1 minute at 60+X°C
(depend on primer-should be 2 degree lesser that the annealing temperature) and
1.50 minutes at 72°C. (iii) 1 cycle of extension step at 72°C for 5 minutes, the
product was then put on hold at 4°C for 200 cycles or until use.

Touchdown PCR
Touchdown PCR was chosen since it was more suitable for varies annealing
temperature of each primer. PCR master mix, Go Tag Green cat#M7122, was
purchased from Promega Corporation (Madison, WI). Per reaction of PCR mixture
contain 12.5 ul of master mix, 4.5 ul of nuclease free water, 2.5 ul of each forward
and reverse primer at 1 uM working concentration and 2 ul of DNA template. 1 ul of
DMSO (Thermo Fisher Scientific Inc. Pittsburgh, PA) was also added to improve the
denaturation of CG-rich region in bacteria DNA double helix strands.
Amplification was performed using theMastercycler gradient (Eppendorf AG.
Hamburg, Germany) with the following condition: (i) a hot start step of 2 minutes at
94°C and (ii) an initial step consisting of 1 minute at 94°C, 1 minute of 60-56°C with 2
cycles for each degree Celsius and 1 minute of 72°C.Then (iii) 30 cycles of 1 minute
at 94°C, 1 minute of 55°C and 1 minute of 72°C.Final extension (iv) of 7 minutes at
72°C and put on hold at 4°C.
To ensure the integrity of the DNA, amplification products from PCR were
subjected to gel electrophoresis using 2% (W/V) agarose gel (Promaga BioSciences.

20
San Luis Obispo, CA) and were observed by Ethidium bromide staining. UV imager
for qualitative analysis was used to read the results.

Cloning and Sequencing
The PCR products were purified using QIAquick PCR Purification kit 250
(QIAGEN INC. Valencia, CA) following the manufacture protocol. Briefly, added 5
volumes of PBI buffer were added to 1 volume of PCR product and mixed. The
mixture was transferred into the column that had been inserted into the 2 ml
collection tube, then centrifuged for 60 seconds, discarded the flow-through. To
wash, 0.75 ml PE buffer was added into the column then centrifuge for 60 seconds,
discarded the flow-through. Centrifuged the column for an additional 1 minute and
moved the column to the new 1.5 micro centrifuge tube. To eluted DNA, added 30 ul
of nuclease free water to the center of the membrane, let the column stand for 1
minute and centrifuged for 1 minute. Increased DNA concentration by pipetted the
flow-through and put back to the center of the membrane and centrifuged for 1
minute.
Purified DNA fragment was then inserted into plasmid and transform into 1shot cells using TopoTA cloning kit (Invitrogen Corporation. Carlsbad, CA) according
to the protocol. Briefly, the PCR mastermix of 37.5 ul of nuclease free water, 5 ul 10x
easy A buffer, 4ul of 2.5 mM dNTP mix, 1ul each of 10 uM working concentration
forward and reverse primer and 0.5 ul of Easy A enzyme were mixed with 1 ul of 100
ng of DNA template then put in the thermocycler set condition at (i) 4 minutes at
95°C then (ii) 35 cycles of 30 seconds at 95°C, 30 seconds at 60°C and 60 seconds
at 72°C. The last step of final extension of (iii) 7 minutes at 72°C, the product was
then put on hold at 4°C until use. The 3’ overhangs were added to the PCR product
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on ice using 1 unit of TAQ (0.5uL). Heated 8-10 minutes at 72°C and returned to ice.
Added 1 ul of salt solution and 1 ul of vector to 4 ul of PCR product and incubated 5
minutes at room temperature then returned to ice. To transform the vector into 1-shot
cells, 2 ul of cloning reaction were added and mixed gently, put on ice for 5 minutes,
heat shocked in 42°C water bath and immediately put back to ice. The next step was
to incubate the cells with 250 ul of SOC in 37°C shaking incubator for 1 hour then
plated using x-gal as the indicator, let the cells grow for 24 hours at 37°C. Tested the
fidelity of the cloning, the screening PCR were then performed. The mixtures of 15.1
ul of nuclease free water, 2.0 ul of 10x buffer, 1.2 ul of 25 mM working concentration
of magnesium, 0.8 ul of 2.5 mM of dNTP mix, 0.4 ul each of screening forward and
reverse primer and 0.1 L of Taq polymerase were mixed with the coloniesthat were
picked by the pipette tip and process to the themocycler the same condition as
above.
After the screening PCR was done, the plasmic cells of choice were going
through the rapid isolation of plasmid DNA using Promega Wizard Plus system
(Promega Corporation. Madison, WI). This system can be used to isolate plasmid
from E. coli hosts, which we were using as one-shot cell suitable for the plasmid is
less than 20,000 bp in size. The principle of this method is to lyse bacteria cell to
separate out the plasmid using column and a series of wash solutions.
The plasmid was then sent to Applied Genomics Technology Center (Detroit,
MI) for sequencing. The predicted products of gene from each bacterium were used
to

compare

for

matching

genome

using

the

BLAST

algorithm

(www.ncbi.nlm.nih.gov). After linearized the plasmid and serial dilutions were
performed and keep in -20°C until needed.
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RESULTS
All primers were sensitive and specific for the strain they were designed to
target when amplified with the diluted ATCC DNA. The sequence of the clone
products were compared (http://blast.ncbi.nlm.nih.gov) and showed to be 96-100%
similarity to the 16s r RNA sequence of Bifidobacterium spp. and Lactobacillus spp.
as expected.
Total bacteria in the test samples were qualified by Touchdown PCR. Gel
electrophoresis of PCR product proved the presence of bacteria DNA in test
samples. The concentrations and quality of the sample solutions were also analyzed
by spectrophotometer.

ZR fecal kit
After collecting 0.15 g of fecal sample, extracted following the manufacturers
procedure, the products were inspected using Nanodrop spectrophotometer (Thermo
scientific Inc. Pittsburgh, PA). The result shows that DNA yield was not sufficient
(lower than 250 ng/ul) and the 260/280 ratio were lower than 1.8. Then we repeated
the experiment again using fresh fecal sample, which increased yield of DNA,
storage sample in frozen form did not affect the quality of the sample. The
experiment shows that 0.075 g was sufficient enough for DNA extraction. To improve
texture and lysis ability, fecal material were soaked in nuclease free water for 10
minutes, then hand homogenized and vertex using bench top vertex at 8,000 xg for 5
minute. When finished the last step in protocol, transferred elute DNA to prepared
IV-HRC spin filter one more time. The dilution of elution buffer has no effect to the
extraction method.
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During the quantization of extracted DNA by Nanodrop spectrophotometer, it
was found that the 260/280 ratio failed to reach the acceptable range. Even though
the reason might come from the preservatives that are used in the column and might
not affect the usability of the product, but to ensure the quality, the columns were
washed with 400 ul of nuclease free water to get rid of access reagent. The result
showed that 260/280 ratio value had improved. (Figure 2)
Since some of the PCR gel results showed multiple bands, the possibility
might be RNA contamination. The company claimed that this kit was designed for
complete RNA hydrolysis. But to ensure the results, we extended time period when
feces mixed with DNA binding buffer. Results still showed multiple bands and smear
in PCR gel. So later on, RNase treatment was done on DNA extraction solution
before running PCR with Beta-actin primer. The results showed that the additional
band disappeared in some experiments, but some were still present.
The 20,25,30 and 35 cycles of PCR amplified with Beta-actin primer were
performed in combination with the different dilution of extracted DNA and the results
of PCR gel showed that there are linear relationship between the concentration of
DNA presented in the samples and the intensity of the band when exposed to UV
light.
Attempting to find the right annealing temperature, gradient PCR was
performed on 55.1, 56.1, 56.8, 58.2, 58.9, and 60.0 °C using BiBre primer. The
template was amplified twice. First, used ATCC DNA amplified with Bifid1 primer.
Then inserted into plasmid, grew and amplified again using species specific primer.
Results show that all of the annealing temperatures were suitable to amplify these
bacteria DNA. (Figure.3)
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Touchdown PCR was later used in the experiments but the DNA extraction
using ZR fecal kit still failed to show the acceptable amplification signal.

DNAzol Direct
Since ZR Fecal kit failed to provide the DNA which can be amplified by PCR,
DNAzol was chosen. First, the experiment was focused on the appropriate amount of
feces used since too much sample can decrease the efficiency of the DNAzol
solution. Experiments were attempted to find the appropriate among in range of 1-10
mg of fresh frozen mouse feces. The best yield came from using the pipette tip to
touch the sample (same method when performing plasmid recombinant screening
PCR), and mixed with 0.1 ml Nuclease-free water than added DNAzol direct solution.
Next, we continue on the trial of various incubation temperatures, incubation time
and the method of mixing (Table.3), results in the best condition which showed; for
incubation temperature, between 85°C- 90°C and 95°C, 95°C yield the best results
and 15 minutes of incubation time is better than 10 minutes. For mixing method,
several techniques of hand homogenized and different length of vertex time were
used. The results showed that the more the sample broke down, the better extraction
of DNA. So we decided to use 30 seconds on bench top vertex. Centrifuge at 32000
rpm for 1 minute after the extraction process helped improve the quality also.
After performing touchdown PCR using the template DNA extracted via this
method, amplified with both genus specific and species specific primers; results
shown in Table 3. At first, the PCR gel results showed band in negative control which
were thought of as contamination during PCR mixture preparation. But later on we
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found out that the reason was from miscalculation of primer concentration resulted in
primer dimerization.
To ensure that there is no PCR inhibitor present in the fecal material,
experiment was formulated by mixing the fecal material with Bifidobacterium breve
15701from www.ATCC.org, which grew into live cell culture. PCR gel results show
the DNA amplification of BiBre and Bifid1 primer on mixture of feces with live cell
culture and dry cell, but failed to show signal on fresh feces, fresh frozen feces and
feces that were collected directly from young mice colon incision. (Figure 4-a, b)
The experiment was repeated again using Lacto and Bifid2 primer. Results
showed that, with touchdown PCR, both primers could detect the presence of
Lactobacillus spp. and Bifidobacterium spp. in fecal material that was collected
directly from mice colon incision. Bifid2 primer could also detected bacteria sample
that was collected by scraping mucosa of mouse colon, but not present in Lacto
primer PCR result. Both primers could not amplify DNA of the whole colon without
incision. (Figure 5-a, b)
Touchdown PCR was performed at 45 cycles on serial dilution of
Bifidobacterium breve colony to check the sensitivity of Bifid1 primer and BiBre
primer. The results show that G.Bibif1 primer could detect the presence of
Bifidobacterium breve as low as the dilution of 10-5 and for BiBre primer, it was the
dilution of 10-6. (Figure 6-a, b)
The sensitivity of Bifid2 primer was also checked by detecting the serial
dilution of Bifidobacterium breve cell culture DNA, the result shows that it could
detect the DNA presence as low as dilution of 10-8. (Figure 6-c)
The experiment continues further to see the lowest concentration of diluted
fecal DNA sample that Bifid1 and BiBre primer could detect. The gel electrophoresis
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results show that there are multiple bands present in both fresh and fresh frozen
fecal samples. In BiBre primer can detect as low as 1:100 times dilution in both fresh
and fresh frozen fecal samples. This is the unknown DNA concentration since the
sample started off with pipette tip touching method, and the extracted DNA in
DNAzol solution could be used in PCR mixture without unnecessary PCR purification
step. In case of G.Bibif1 primer, results show multiple bands and could detect as low
as 1:50 times dilution in fresh fecal sample but detected none in fresh frozen fecal
sample. (Figure 7-a, b, c)
DNA extraction from fecal matter was used to test Lacto primer sensitivity.
The results show, at the primer concentration of 0.1 uM, the last concentration
detection was at 394 ag. (Figure 8)
The serial dilution of DNA extracted from fresh frozen feces was amplified
with Lacto primer. The results show that primer could detect as low as 1:100 times
dilution (started off with pipette tip touching method as DNAzol Direct protocol).
(Figure 9)

TA Sub-Cloning and Sequencing
The primer accuracy were checked by compared both genus specific (Bifid1
primer) and species specific primers (BIA, BiBre, BiLon primer). PCR amplified
results to known bacteria species ordered from www.ATCC.org ; Bifidobacterium
adolescentis catalog number 15703D, Bifidobacterium breve catalog number
15700D-5 and Bifidobacterium infantis catalog number 15697D.
In genus specific primer shows 99% match with B. longum sub species
infantis, B. breve and B. adolescentis. In case of species specific primer, the results
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show that its 96% similar to B. longum sub species infantis and 100% similar to B.
breve and B. adolescentis as expected.
The first sample using fresh feces collected from young mice, extracted DNA
using ZR Fecal kit. Then the DNA was amplified by touchdown PCR, using Bifid1
primer. The product was cloned and sent for sequencing. The resulting sequence
was compared against 16S rRNA of each species, and the sample sequence
showed to be 96% matched to Bifidobacterium thermacidophilum subsp.
Thermacidophilum.
While developing the DNAzol direct extraction method, the PCR product
collected from young mice feces amplified with Bifid1 were sent to sequencing but
the results show no signal. The size of this DNA fragment was 250-550 base pair.
In case of DNAzol Direct DNA extracting method, fresh frozen fecal sample
was amplified with Lacto primer. Sequencing results show 99% match with
Lactobacillus reuteri 16S ribosomal RNA gene.
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Primers test
Sample sequencing results compared to a query sequence from database of
bacteria using BLAST program. (http://blast.ncbi.nlm.nih.gov)

Bifid1 genus specific primer amplified on ATCC Bifidobacterium breve catalog
number 15700D-5, results in 99% match Bifidobacterium breve strain 885 16S
ribosomal RNA gene.
Query

1

ATGGCGGGGTAACGGCCCACCATGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGC

60

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

41

ATGGCGGGGTAACGGCCCACCATGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGC

100

Query

61

CACATTGGGACTGAGATACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCA

120

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

101

CACATTGGGACTGAGATACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCA

160

Query

121

CAATGGGCGCAAGCCTGATGCAGCGACGCCGCGTGAGGGATGGAGGCCTTCGGGTTGTAA

180

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

161

Query

181

CAATGGGCGCAAGCCTGATGCAGCGACGCCGCGTGAGGGATGGAGGCCTTCGGGTTGTAA

220

ACCTCTTTTGTTAGGGAGCAAGGCACTTTGTGTTGAGTGTACCTTTCGAATAAGCACCGG

240

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

221

ACCTCTTTTGTTAGGGAGCAAGGCACTTTGTGTTGAGTGTACCTTTCGAATAAGCACCGG

280

Query

241

CTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGGTGCAAGCGTTATCCGGAATTATTG

300

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

281

CTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGGTGCAAGCGTTATCCGGAATTATTG

340

Query

301

GGCGTAAAGGGCTCGTAGGCGGTTCGTCGCGTCCGGTGTGAAAGTCCATCGCTTAACGGT

360

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

341

GGCGTAAAGGGCTCGTAGGCGGTTCGTCGCGTCCGGTGTGAAAGTCCATCGCTTAACGGT

400

Query

361

GGATCCGCGCCGGGTACGGGCGGGCTTGAGTGCGGTAGGGGAGACTGGAATTCCCGGTGT

420

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

401

Query

421

GGATCCGCGCCGGGTACGGGCGGGCTTGAGTGCGGTAGGGGAGACTGGAATTCCCGGTGT

AACGGTGGAATGTGTAGATATCGGGAAGAACACCAAGGGCGAA

463

|||||||||||||||||||||||||||||||||||| ||||||
Sbjct

461

AACGGTGGAATGTGTAGATATCGGGAAGAACACCAATGGCGAA

503

460
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BiLon species specific primer amplified on ATCC Bifidobacterium infantis
catalog number 15697D, results in 96% match with Bifidobacterium longum gene for
16S rRNA strain: JCM 7011.

Query

4

CGCTTGCTCCCCGATAAAAGAGGTTTACAACCCGAAGGCCTCCATCCCTCACGCGGCGTC

63

Sbjct

385

CGCTTGCTCCCCGATAAAAGAGGTTTACAACCCGAAGGCCTCCATCCCTCACGCGGCGTC

326

Query

64

GCTGCATCAGGCTTGCGCCCATTGTGCAATATTCCCCACTGCTGCCTCCCGTAGGAGTCT

123

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

325

GCTGCATCAGGCTTGCGCCCATTGTGCAATATTCCCCACTGCTGCCTCCCGTAGGAGTCT

266

Query

124

GGGCCGTATCTCAGTCCCAATGTGGCCGGTCGCCCTCTCAGGCCGGCTACCCGTCGAAGC

183

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

265

Query

184

GGGCCGTATCTCAGTCCCAATGTGGCCGGTCGCCCTCTCAGGCCGGCTACCCGTCGAAGC

206

CACGGTGGGCCGTTACCCCGCCGTCAAGCTGATAGGACGCGACCCCATCCCATACCGCGA

243

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

205

CACGGTGGGCCGTTACCCCGCCGTCAAGCTGATAGGACGCGACCCCATCCCATACCGCGA

Query

244

AAGCTTTCCCAGAAGACCATGCGATCAACTGGAA

Sbjct

145

146

277

||||||||||||||||||||||||||||||||||
AAGCTTTCCCAGAAGACCATGCGATCAACTGGAA

112

BiBre species specific primer amplified on ATCC Bifidobacterium breve
catalog number 15700D-5 results in 100% match with Bifidobacterium breve gene
for 16S rRNA strain: JCM 1192.

Query

1

ACAAAGTGCCTTGCTCCCTAACAAAAGAGGTTTACAACCCGAAGGCCTCCATCCCTCACG

60

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

404

Query

61

ACAAAGTGCCTTGCTCCCTAACAAAAGAGGTTTACAACCCGAAGGCCTCCATCCCTCACG

345

CGGCGTCGCTGCATCAGGCTTGCGCCCATTGTGCAATATTCCCCACTGCTGCCTCCCGTA

120

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

344

CGGCGTCGCTGCATCAGGCTTGCGCCCATTGTGCAATATTCCCCACTGCTGCCTCCCGTA

285

30
Query

121

GGAGTCTGGGCCGTATCTCAGTCCCAATGTGGCCGGTCGCCCTCTCAGGCCGGCTACCCG

180

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

284

GGAGTCTGGGCCGTATCTCAGTCCCAATGTGGCCGGTCGCCCTCTCAGGCCGGCTACCCG

225

Query

181

TCGAAGCCATGGTGGGCCGTTACCCCGCCATCAAGCTGATAGGACGCGACCCCATCCCAT

240

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

224

TCGAAGCCATGGTGGGCCGTTACCCCGCCATCAAGCTGATAGGACGCGACCCCATCCCAT

Query

241

GCCGCAAAGGCTTTCCCAACACACCATGCGGTGTGATGGAGCATCCGG

165

288

||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

164

GCCGCAAAGGCTTTCCCAACACACCATGCGGTGTGATGGAGCATCCGG

117

BIA species specific primer amplified on ATCC Bifidobacterium adolescentis
catalog number 15703D results in 100% match with Bifidobacterium adolescentis
strain ATCC 15703 16S ribosomal RNA gene.

Query

1

GGAAAGATTCTATCGGTATGGGATGGGGTCGCGTCCTATCAGCTTGATGGCGGGGTAACG

60

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

208

Query

61

GGAAAGATTCTATCGGTATGGGATGGGGTCGCGTCCTATCAGCTTGATGGCGGGGTAACG

267

GCCCACCATGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACATTGGGACTGA

120

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

268

GCCCACCATGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACATTGGGACTGA

327

Query

121

GATACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGC

180

Sbjct

328

GATACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGC

387

Query

181

CTGATGCAGCGACGCCGCGTGCGGGATGACGGCCTTCGGGTTGTAAACCGCTTTTGACTG

240

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

388

CTGATGCAGCGACGCCGCGTGCGGGATGACGGCCTTCGGGTTGTAAACCGCTTTTGACTG

Query

241

GGAG

244

||||
Sbjct

448

GGAG

451

447
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Fecal samples test
Bifid1 genus specific primer amplified on fecal sample results in 96% match
with Bifidobacterium thermacidophilum subsp. thermacidophilum gene for 16S rRNA,
strain: NBRC 106100.

Query

1

CTCCTGGAAACGGGTGGTAATGCCGGATGTTCCCGCGCCCCGCATGGGGTGCGGGGAGAG

60

||||||||||||||||||||||||||||||||||||||||||||||||||||||||| ||
Sbjct

124

Query

61

CTCCTGGAAACGGGTGGTAATGCCGGATGTTCCCGCGCCCCGCATGGGGTGCGGGGAAAG

183

CTTTTGCGGCGTGGGATGGGGTCGCGTCCTATCAGCTTGTTGGCGGGGTGAGGGCCCACC

120

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

184

CTTTTGCGGCGTGGGATGGGGTCGCGTCCTATCAGCTTGTTGGCGGGGTGAGGGCCCACC

243

Query

121

AAGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACATTGGGACTGAGATACGG

180

Sbjct

244

AAGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACATTGGGACTGAGATACGG

303

Query

181

CCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGC

240

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

304

CCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGC

363

Query

241

AGCGACGCCGCGTGCGGGATGGGGGCCTTCGGGTTGTAAACCGCTTTTGTTTGGGAGCAA

300

|||||||||||||||||||||| |||||||||||||||||||||||||||||||||||||
Sbjct

364

AGCGACGCCGCGTGCGGGATGGAGGCCTTCGGGTTGTAAACCGCTTTTGTTTGGGAGCAA

423

Query

301

GCCCTTCGGGGTGAGTGTACCTTTCGAATAAGCACCGGCTAACTACGTGCCAGCAGCCGC

360

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

424

GCCCTTCGGGGTGAGTGTACCTTTCGAATAAGCACCGGCTAACTACGTGCCAGCAGCCGC

483

Query

361

GGTAATACGTAGGGTGCGAGCGTTATCCGGATTTATTGGGCGTAAAGGGCTCGTAGGCGG

420

Sbjct

484

GGTAATACGTAGGGTGCGAGCGTTATCCGGATTTATTGGGCGTAAAGGGCTCGTAGGCGG

543

Query

421

TTCGTCGCGTCCGGTGTGAAAGTCCATCGCCTCACGGTGGATCTGCGCCGGGTACGGGCG

480

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

|||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||
Sbjct

544

TTCGTCGCGTCCGGTGTGAAAGTCCATCGCCTAACGGTGGATCTGCGCCGGGTACGGGCG

603

Query

481

GGCTGGAGTGCGGTAGGGGAGACTGGAATTCCCGGTGTAACGGTGGAATGTGTAGATATC

540

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

604

GGCTGGAGTGCGGTAGGGGAGACTGGAATTCCCGGTGTAACGGTGGAATGTGTAGATATC

663

32

Query

541

GGGAAGAACACCAAGGGCGAA

561

|||||||||||||| ||||||
Sbjct

664

GGGAAGAACACCAATGGCGAA

684

Lacto genus specific primer amplified on fecal sample results in 99% match
with Lactobacillus reuteri strain MF2-2 16S ribosomal RNA gene.

Query

300

CACCGCTACACATGGAGTTCCACTCTCCTCTTCTGCACTCAAGTCGCCCGGTTTCCGATG

359

|||||||||||||||||||||||| |||||||||||||||||||||||||||||||||||
Sbjct

676

Query

360

CACCGCTACACATGGAGTTCCACTGTCCTCTTCTGCACTCAAGTCGCCCGGTTTCCGATG

617

CACTTCTTCGGTTAAGCCGAAGGCTTTCACATCAGACCTAAGCAACCGCCTGCGCTCGCT

419

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

616

CACTTCTTCGGTTAAGCCGAAGGCTTTCACATCAGACCTAAGCAACCGCCTGCGCTCGCT

557

Query

420

TTACGCCCAATAAATCCGGATAACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACG

479

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

556

TTACGCCCAATAAATCCGGATAACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACG

497

Query

480

TAGTTAGCCGTGACCTCCTGGTTGGATACCGTCACTGCGTGAACAGTTACTCTCACGCAC

539

|||||||||||||| | |||||||||||||||||||||||||||||||||||||||||||
Sbjct

496

TAGTTAGCCGTGACTTTCTGGTTGGATACCGTCACTGCGTGAACAGTTACTCTCACGCAC

437

Query

540

GTTCTTCTCCAACAACAGAGCTTTACGAGCCGAAACCCTTCTTCACTCACGCGGTGTTGC

599

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

436

GTTCTTCTCCAACAACAGAGCTTTACGAGCCGAAACCCTTCTTCACTCACGCGGTGTTGC

Query

600

TCCATCAGGCTTGCGCCCATTGTGGAAGATTCCCTACTGCT

640

|||||||||||||||||||||||||||||||||||||||||
Sbjct

376

TCCATCAGGCTTGCGCCCATTGTGGAAGATTCCCTACTGCT

336

377
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Figure 3 Electrophoresis gel of Gradient PCR in different annealing temperature,
using BiBre primer amplified ATCC DNA of B. breve, B.adolescentis and B. infantis
at 55.1, 56.1, 56.8, 58.2, 58.9 and 60.0 °C.
The figure shows that BiBre primer can be used at the annealing temperature
ranging from 55.1-60.0°C to detect the presence of B. breve, B.adolescentis and B.
infantis.
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Figure 4-a Electrophoresis gel of Touch-down PCR amplification products, using
BiBre primer, from live cell culture, dry cell culture and feces.
Samples used - Lane1,2) 1:2 dilution of ATCC B. breve DNA; Lane3,4)ATCC B.
breve dry cell culture; Lane5,6) ATCC B. breve live cell culture; Lane7,8) fresh
collected feces; Lane9,10) frozen fresh collected feces; Lane11,12) feces collected
directly from colon incision; Lane13,14) fresh collected feces combined with dry cell
culture; Lane15,16) frozen fresh collected feces combined with dry cell culture;
Lane17) fresh collected feces combined with live cell culture; Lane18) frozen fresh
collected feces combined with live cell culture.
From this figure, the results show that BiBre primer could detect the presence
of B.breve in the form of DNA extraction, live and dry cell cultures with or without the
presence of fecal material. This proves that there is no PCR inhibitor present in
feces. This extracting method didn’t yield the results that are usable for PCR when
performed on fecal samples alone.
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Figure 4-b Electrophoresis gel of Touch-down PCR amplification products, using
Bifid1 primer, from live cell culture, dry cell culture and feces.
Samples used - Lane1) 1:2 dilution of ATCC B. breve DNA; Lane2) ATCC B. breve
dry cell culture; Lane3) ATCC B. breve live cell culture; Lane4) fresh collected feces;
Lane5) frozen fresh collected feces; Lane6) feces collected directly from colon
incision; Lane7) fresh collected feces combined with dry cell culture; Lane8) fresh
collected feces combined with live cell culture.
In the case of Bifid1 primer, the results also showed that it could be detected
in the presence of B. breve in the form of DNA extraction, live and dry cell culture
with or without the presence of fecal material. It didn’t yield the results that are
usable for PCR when performed on fecal samples alone.
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Figure 5-a Electrophoresis gel of Touch-down PCR amplification products, using
Bifid2 primer, from mouse colon mucosa scraping, mouse whole colon and feces.
Samples used – Lane1) fresh collected feces; Lane2) frozen fresh collected feces;
Lane3) feces collected directly from colon incision; Lane4) mouse colon mucosa
scraping; Lane5) mouse whole colon.
In the case of Bifid2 primer, the results showed that it could detect some
Bifidobacterium in mouse colon feces and mouse colon mucosa but couldn’t detect
fecal material in both freshly collected and pre-frozen feces, the whole colon also did
not yield the results.
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Figure 5-b Electrophoresis gel of Touch-down PCR amplification products, using
Lacto primer, from mouse colon mucosa scraping, mouse whole colon and feces.
Samples used – Lane1) fresh collected feces; Lane2) frozen fresh collected feces;
Lane3) feces collected directly from colon incision; Lane4) mouse colon mucosa
scraping; Lane5) mouse whole colon.
Lacto primer could detect the presence of Lactobacillus spp. DNA in the PCR
product of freshly collected feces DNA, the pre-frozen feces and the feces that
collected directlyfrom colon incision. The PCR results failed to show signal in the
case of the sample of mouse mucosa and whole mouse colon.
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Figure 6-a Electrophoresis gel of Touch-down PCR amplification products, testing
on Bifid1 primer sensitivity test, using B. Breve live colony as a template.
Samples used – Lane1) no dilution; Lane2) 10-1 dilution; Lane3) 10-2 dilution; Lane4)
10-3 dilution; Lane5) 10-4 dilution; Lane6) 10-5 dilution; Lane7) 10-6 dilution.

Figure 6-b Electrophoresis gel of Touch-down PCR amplification products, testing
on BiBre primer sensitivity test, using B. Breve live colony as a template.
Samples used – Lane1) no dilution; Lane2) 10-1 dilution; Lane3) 10-2 dilution; Lane4)
10-3 dilution; Lane5) 10-4 dilution; Lane6) 10-5 dilution; Lane7) 10-6 dilution.
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Figure 6-c Electrophoresis gel of Touch-down PCR amplification products, testing
on Bifid2 primer sensitivity test, using B. Breve live cell colony as a template.
Samples used – Lane1) no dilution; Lane2) 10-1 dilution; Lane3) 10-2 dilution; Lane4)
10-3 dilution; Lane5) 10-4 dilution; Lane6) 10-5 dilution; Lane7) 10-6 dilution; Lane8)
10-7 dilution; Lane9) 10-8 dilution.
Bifid1 primer and BiBre primer sensitivity test on B. Breve live cell colony
showed that the primer could detect the presence of bacteria DNA as low as the
dilution of 10-6, while Bifid2 primer was at 10-8. The concentration was unknown
since the sample was collected by touching the pipette tip directly to the colony.
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Figure 7-a Electrophoresis gel of Touch-down PCR amplification products, using
BiBre primer, from fresh collected feces DNA extraction by DNAzol direct solution.
Samples used – Lane1) 1:10 dilution of ATCC B. Breve; Lane2) 1:10 dilution of DNA
extraction; Lane3) 1:20 dilution of DNA extraction; Lane4) 1:50 dilution of DNA
extraction; Lane5) 1:100 dilution of DNA extraction.

Figure 7-b Electrophoresis gel of Touch-down PCR amplification products, using
BiBre primer, from frozen fresh collected feces DNA extraction by DNAzol direct
solution.
Samples used – Lane1) 1:10 dilution of ATCC B. Breve; Lane2) 1:10 dilution of DNA
extraction; Lane3) 1:20 dilution of DNA extraction; Lane4) 1:50 dilution of DNA
extraction; Lane5) 1:100 dilution of DNA extraction.
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Figure 7-c Electrophoresis gel of Touch-down PCR amplification products, using
Bifid1 primer, from fresh collected and frozen fresh collected feces DNA extraction
by DNAzol direct solution.
Samples used – Lane1) 1:10 dilution of ATCC B. Breve; Lane2) 1:10 dilution of fresh
collected feces DNA extraction; Lane3) 1:50 dilution of fresh collected feces DNA
extraction; Lane4) 1:10 dilution of frozen feces DNA extraction; Lane5) 1:50 dilution
of frozen feces DNA extraction.
When attempt to amplify the DNA extraction using Bifid1 primer and BiBre
primer, the PCR

results

showed

multiple

bands

concentration. The template couldn’t solve the problem.

and a decrease in

the
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Figure 8 Electrophoresis gel of Touch-down PCR amplification products, testing on
Lacto primer sensitivity test, using DNA extracted from feces in different
concentration as a template.
Samples used – Lane1) 15.76 ng/ul; Lane2) 7.88 ng/ul; Lane3) 3.94 ng/ul.; Lane4)
3.94×10-1 ng/ul.; Lane5) 3.94×10-2 ng/ul.; Lane6) 3.94×10-3 ng/ul.; Lane7) 3.94×10-4
ng/ul.; Lane8) 3.94×10-5 ng/ul.; Lane9) 3.94×10-6 ng/ul.; Lane10) 3.94×10-7 ng/ul.

Figure 9 Electrophoresis gel of Touch-down PCR amplification products, using on
Lacto primer ,on DNA extracted from frozen fresh collected feces using DNAzol
direct solution.
Samples used – Lane1) 1:10 dilution; Lane2) 1:2 dilution; Lane3) 1:5 dilution; Lane4)
1:7 dilution; Lane5) 1:100 dilution of frozen feces DNA extraction.
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Lacto primer could detect the presence of DNA extracted via this method
even at the low concentration of DNA present. In primer sensitivity test (fig.8), the
lowest concentration detected was at 3.94×10-7 ng/ul.
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CONCLUSION
ZR Fecal kit
1. Fresh collected feces worked better than dry. Fecal sample could be frozen
and stored at -20°C without decline in DNA quality.
2. To improve the bacteria-lysis ability, many texture improving techniques were
used i.e.; hand homogenization, bench top vertex. The more the samples
broke down, the better the results.
3. PCR method was started off with different annealing temperatures (gradient
PCR) and number of PCR cycles. Later on, TDPCR was chosen in order to
cover more temperature ranges and reduced the amplification of nonspecific
sequences. For PCR reaction solution, Go Tag Green with DMSO gave the
best amplifying results.
4. PCR results from Beta-actin primer and Bifid1 primer showed inconsistent
results, either 2 bands or smear. The dilution of template and RNase
treatment were tried but could not improve the outcome.
5. ZR Fecal Kit, after adjusting the protocol, could not extract bacteria DNA at
acceptable spectrophotometer’s 260/280 wave length ratio. The concentration
of bacteria DNA was low, and could not show acceptable results on
electrophoresis gel after PCR.
6. However, with the correct G.bidif1 primer concentration, mouse fecal DNA
could be amplified by PCR. The sequence matched 96% to Bifidobacterium
themacidophilum. For species specific primer, they fail to give acceptable
PCR results.
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DNAzol Direct
1. The most suitable among mouse fecal samples, either fresh or frozen, was
obtained by touching the pipette tip to the sample (same method as screening
PCR in plasmid cloning procedure). But this DNA extraction method needed
to extract daily since the DNAzol Direct solution is not suitable to store DNA
sample.
2. The most efficient incubation condition was 95°C for 15 minutes on heating
block, then vertex for 30 seconds followed by centrifuge at 32000 rpm for 1
minute.
3. DNAzol Direct DNA extract method was preferred. Yield from template DNA
could be amplified in PCR and showed results in electrophoresis gel and it
required fewer steps in protocol.
4. There was no PCR inhibitor in feces. Experiments by mixing ATCC culture
into fecal sample and results in amplification signal on PCR gel.
5. Fecal DNA extraction by this method, when amplified with Lacto genus
specific primer, yielded 99% match with sequence of Lactobacillus reuteri in
database.
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The reaction sensitivity test
The sensitivity of reactions was evaluated by serial dilution of ATCC DNA:
B. adolescentis, B. breve, and B. infantis.
1. Bifid1 genus specific primer, with template from all 3 species, could detect
DNA up to a dilution of 10-10, which contained approximately 10 ag of DNA.
2. For species specific primers,
-BIA primer could detect DNA up to a dilution of 10-8, or 1 fg of DNA.
-Both BiLon and BiBre primer could detect DNA up to a dilution of 10-7,
or 10 fg of DNA.

The serial dilution of ATCC Bifidobacterium breve culture was also used as a
template to evaluate the sensitivity of the reaction.
1. Bifid1 genus specific primers could detect DNA up to the dilution of 10-5 or
approximate amount of 1 pg of DNA, while Bifid2 was 10-8 or approximate
amount of 1 fg of DNA.
2. BiBre species specific primer could detect DNA up to the dilution of 10-6, or
approximate amount of 100 fg of DNA.

The PCR product of

Bifid1 primer amplified against ATCC bacteria DNA:-

resulted in 99% match with all 3 bacteria sequences (B. breve, B. Adolescentis, and
B. Longum). When using BiBre and BIA primers amplified against B. breve and B.
infantis ATCC DNA, the sequences were 100% similar to each species in bacteria
database. For BiLon primer, the results yield 96% match.
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DISCUSSION
During the sample collection, we used both young and old mice. The disparity
in age of the mice might play an important role in the occurrence of bacteria detected
in fecal samples, due to unequally late development of the young mice’s intestinal
ecosystems (67).
The presence of bacteria in the feces might not represent the type or quantity
of bacteria that inhabitant the colon. From the experiments, some types can be
detected more in colons but not in feces. The reason might be attributable to the
surface protein called adhesion in the bacteria cell wall, which aids the binding of
that bacterium to the receptor molecule on the surface of a susceptible host cell. This
type of contact enables the bacteria to adhere, colonize, and resist physical removal
like flushing.
For example, Bifidobacterium bifidum has been shown to have the highest
adhesion to the intestinal epithelial cell (IEC), using the specific lipoprotein called
Bifidobacterial outer protein A (bopA) that helps enhanced adhesion to IEC (68).

Factors that determine or help promote the colonization of each different
bacterium include the mobility which helps increase the chance of connection to host
and spreading of the colonies, in addition to how well the bacteria can adhere and
resist physical removal. Some bacteria can invade the host cell and fight for nutrients
with other species. If the bacteria can defence against the host’s innate immune
defuses system, such as phagocytosis, and adapt to the immune defences, then it
can increase the chance to colonize.

Many factors could come into play in the regulation of the studied microflora,
including local immune mechanism, the substrates supplied by the mucosa,
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interactions between different microbial species, initial digestion transit time, pH, and
the local supply of oxygen (58).

Primer design
16S ribosomal RNA is the species-specific signature sequences of prokaryotic
ribosome used for identifying the bacteria. It consists of 30 small subunits,
approximately 1.5 kb in length. This region acts as a framework and defines the
placement of ribosomal protein. 3’ end of 16S rRNA binds upstream to AUG start
codon on mRNA initiate protein synthesis. It is also interact with 23S rRNA helping 2
ribosomal subunits to bind. This helps to stabilize the right codon-anticodon pairing
in A site (ribosomal-decoding site). 16S rRNA is essential and present at least one
copy in the genome (79).
The primer design targeted the 16S ribosomal RNA, because it is the
conservative regions content, involves the bacteria species essential functions, is
used for generating amplicons, and benefits greatly from the phylogenetic and
taxonomic studies. In PCR technical, the V1-V9 regions of 16S rRNA genes are
usually the target for primer design (67). The over-relaxed match of primer design
can cause PCR failure.
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ZR Fecal Kit
While performing the DNA extraction using the ZR Fecal kit, as show in the
sample number 21,22,23 in table 2, the appearance of fecal lysed solution was
different between each sample regardless of whether they were collected from the
same subject or not. This could be due to the characteristic difference between each
fecal sample i.e. fiber content, moisture content, food particle etc.
The sample quantitative DNA reading via Nano Drop spectrophotometer
showed a value of 260/280 less than expected, possibly due to acidity in the
solution. A simple change in the ionic strength would results in low 260/280 ratio
(70). Another reason for this observation could be a slight shift in wavelength
accuracy of the spectrophotometer, particularly the absorbance curve at 280 nm. For
example, a 1 nm shift could affect as much as a 0.4 difference in the 260/280 ratio.
(www.nanodrop.com). Lastly, the presence of nucleotides in the sample could affect
the overall value of 260/280 ratio. When measuring each nucleotide individually, the
values are as follows. Guanine equals 1.15, Adenine equals 4.50, Cytosine equals
1.51, Uracil equals 4.00, and Thymine equals 1.47 (71). The ratio would depend on
the composition of the nucleic acid that contaminated the sample.
After extraction, samples were processed with the PCR. The results of
electrophoresis gel, extracted DNA using ZR Fecal kit showed multiple bands that
could be the contamination of RNA. The ZR Fecal kit claims that the reagent in the
kit help gets rid of all the RNA. To ensure this, the samples were treated with RNase
to prevent secondary priming. But that still did not solve the problem. The reasons
might due to contamination in negative controls or the accumulation of primer. Some
samples showed smear in the gel that could be non-specific binding of primer to
template DNA.
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Non-specific binding causes by “hair pins” or the DNA-DNA binding. The
results of this secondary structure DNA folding and knotting can decrease the
productivity yield. The trouble can be resolved by adding dimethyl sulfoxide (DMSO)
or glycerol, which helps minimize the secondary structure DNA by preventing the
DNA self-complementarity.
Other causes of non-specific binding include repeating of the DNA template,
undesirable binding of primer and template, and incomplete primer binding which left
5’end unattached to the template. One way to solve these issues is to use
touchdown PCR, which in this experiment did not always yield the best results.
Another method that needs further experimentation includes using hot start
polymerase enzyme. Nested PCR which could also helps lower the amplification on
unexpected primer binding site. Moreover, non-specific binding of primers can be
fixed by manipulation of annealing temperature and/or the magnesium ion
concentration (72).
Another solution can be obtained from finding the right polymerase enzyme.
For example, one can replace Taq polymerase enzyme with high-fidelity DNA
polymerase. Normally, Taq polymerase has no 3’-5’ exonuclease activity which is
prone to error amplification of DNA product, while these enzymes have engineered
3’-5’ exonuclease activity which provide error-proof reading during synthesis.
The concentrations of each reaction mixture are very important. Too much or
too little of each part can cause PCR failure. From this experiment, primers
concentration was 10 times too high, which results in primer dimerization. Primer
dimerization causes the annealing of 3’ end from one primer to another, and then
primer extends to complete the synthesis of the DNA strand. In this experiment, the
solution was to find the optimum concentration of primer. Other conditions that
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should be studied further include the increasing of MgCl2 concentration, the
increasing or decreasing of annealing temperature, and the use of different primers
(the longer base pair trend to be more specific).
In this study, the primers that were used were based on previous studies,
which had been designed and could be readily purchased. These primers could be
improved to achieve a better result. For example, to decrease non-specific priming
the primer sequence should have C-G content between 40 and 60%. The distribution
of C-G should be divided equally throughout the primer strands, and C-G sequence
should not position at 3’ end of the primer.
There are other possibilities such as using too much deoxy nucleotides
(dNTPs) which has the ability to bind to magnesium ion and can decrease the
magnesium ion concentration in the solvent.
Magnesium ion should be added as the thermostable DNA polymerase cofactor. If the concentration is too low, this could impair the working ability of Taq
polymerase. Using too much can cause double stranded DNA stabilization,
preventing completion of the denaturing process of the DNA strands. In case of nonspecific binding, high magnesium concentration aids the binding of incorrect
template and primer.

DNAzol Direct
One challenge that needs to be overcome in recovery of DNA is finding the
lysis method that could penetrate peptidoglycan, the heavily cross-linked structure in
gram-positive bacteria cell wall. While conducting the experiment, many conditions
and methods were used in order to cause interference of the cell wall. Some
research found that glycoside hydrolyses enzymatic lysis could improve DNA yield.
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For example, fecal material can be resuspended in bactozol enzyme solution or by
using muramidases enzyme such as lysozyme and mutanolysin that hydrolyze the b1, 4 glycoside linkages in GlcNAc and MurNAc of the glycan backbone (31). Another
possibility for improving lysis DNA yield is to use Labiase from Streptomyces
filvissimus, the enzyme that could lyse gram positive bacteria wall. This enzyme also
contains lysozyme and β-N-acetyl-D-glucosaminidase (73).
Furthermore, since we directly used the mixture of fecal material with DNAzol
direct in PCR mixture, it could be that the presences of multiple substances in fecal
material inhibit the polymerase enzyme in the PCR analysis (74).The amount of fecal
material that is suitable for both the extraction process and the PCR reaction is still in
question.
DNAzol direct was chosen instead of ZR Fecal kit because of the ability to
extract the usable DNA and to reduce the number of steps in the process.
Qualification of Bifidobacterium was performed using touchdown PCR with specific
primers. This method was used in this study to avoid the non-specific binding
amplification by gradually declining the annealing temperature template and primer.
The PCR gel results were not as expected, maybe due to the high concentration of
primer that caused primer dimerization.
The present study has several strengths and weaknesses. Some strengths
include: adequate sample size, controlled environment and dietary composition,
adequate length of experimental period, and validation of results through use of two
qualitative techniques (PCR and spectrophotometer) to analyze the same set of
samples. One weakness is the lack of a method to verify the development of the
pathophysiological changes that are claimed to be responsible for the variation in
bacterial levels in the GI tracts of the mice. For example, it would have been helpful
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to analyze the pH of the intestines of the studied mice, or to study the morphology of
the intestinal wells. In addition, the selected measure of outcome (i.e. the
Bifidobacterium DNA in the fecal material) might not truly represent all that occurs in
the flora of the GI tract. The amount of DNA extraction from each fecal sample might
solely indicate the amount of Bifidobacterium population in cecum of the animal
rather than that of the entire GI tract. Finally, the environmental conditions in the
distal bowel, such as depletion of preferred energy substrates, might not be suitable
for the growth of microbiota. Therefore, the DNA results from collected fecal material
might be affected by this limitation (75).
Aging might significantly influence gastrointestinal health, by inhibiting the
growth of beneficial GI microflora. Therefore, further understanding of the regulation
of gut microbiota will offer a basis for future studies to improve GI health in humans.
Bifidobacterium plays an important role in the body, affecting the reactivity of the
immune system and helps the other physiological functions (76). The lower amount
or absence of Bifidobacterium may cause serious health consequences in the GI
tract of the host. For example, colon cancer development can be promoted by the
absence of protective Bifidobacterium strains. To this regard, dietary modifications
such as supplementation of probiotics or prebiotics have been suggested to benefit
in the prevention of diseases such as colon cancer. Indeed, probiotics would provide
and immediately increase Bifidobacterium and prebiotics that would induce the
growth and maintain the health of microbiota population (77). Further research in
animals and humans, especially randomized controlled trials, is warranted.
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Table 1. PCR primers used in this study
Primer

Oligonucleotide sequence

Amplicon
size

Annealing
temp

(Bacteria
species)

( 5'→3')

(bp)

(°C )

341

58

549-563

58

243

58

Lacto [63]
Lactobacillus spp.

F:CACCGCTACACATGGAG
R:AGCAGTAGGGAATCTTCCA

Bifid1 [64]
Bifidobacterium
spp.

F:CTCCTGGAAACGGGTGG

Bifid 2 [65]
Bifidobacterium
spp.

F:TCGCGTC(C/T)GGTGTGAAAG
R:CCACATCCAGC(A/G)TCCAC

BiBIF [64]
B. bifidum

F:CCACATGATCGCATGTGATTG
R:CCGAAGGCTTGCTCCCAAA

278

63

BiBRE [64]
B. breve

F:CCGGATGCTCCATCACAC
R:ACAAAGTGCCTTGCTCCCT

288

60

BiLON [64]
B. longum

F:TTCCAGTGATCGCATGGTC
R:TCSCGCTTGCTCCCCGAT

277

62

BIA [66]
B. adolescentis

F:GGAAAGATTCTATCGGTATGG
R:CTCCCAGTCAAAGCGGTT

244

55

R:GGTGTTCTTCCCGATATCTACA
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Table 2. The ZR Fecal Kit Extraction Method

Texture improvement
sample weight (mg)

condition

Hand homoginized

Bench Top Vertex

1

150

dry feces

no

no

2

150

dry feces

no,but soaked lysis buffer for 10 min

no

3

150

dry feces

no,but soaked lysis buffer for 30 min

no

4

75

dry feces

yes,and soaked in lysis buffer for 30 min

5 min

5

75

fresh feces

yes

5 min

6

150

fresh feces

yes

5 min

7

75

frozen fresh feces

yes

5 min

8

150

frozen fresh feces

yes

5 min

9

75

fresh feces

yes

5 min

10

75

fresh feces

yes

5 min

11

75

fresh feces

yes

5 min

12

75

fresh feces

yes

5 min

13

75

fresh feces

yes

5 min

14

75

fresh feces

yes

5 min

15

75

frozen fresh feces

yes

5 min

16

75

frozen fresh feces

yes

5 min

17

75

fresh feces

yes

5 min

18

75

fresh feces

yes

5 min

19

75

frozen fresh feces

yes

5 min

20

75

frozen fresh feces

yes

5 min

21

75

frozen fresh feces

yes

5 min

22

75

frozen fresh feces

yes

5 min

23

75

frozen fresh feces

yes

5 min
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Procedure adjustment
Sample

Cell Lysis Improvement

DNA Binding Improvement

1

as protocal

1200 ul binding solution as protocal

2

as protocal

1200 ul binding solution as protocal

3

as protocal

1200 ul binding solution as protocal

4

as protocal

1200 ul binding solution as protocal

5

as protocal

1200 ul binding solution as protocal

6

as protocal

1200 ul binding solution as protocal

7

as protocal

1200 ul binding solution as protocal

8

as protocal

1200 ul binding solution as protocal

9

as protocal

1200 ul binding solution as protocal

10

as protocal

1200 ul binding solution as protocal

11

Vertex with lysis buffer 5 min

1200 ul binding solution as protocal

12

Vertex with lysis buffer 10 min
Vertex with lysis buffer 10 min,increase lysis buffer to
1000 ul
Vertex with lysis buffer 10 min,increase lysis buffer to
1000 ul
Vertex with lysis buffer 10 min,increase lysis buffer to
1000 ul
Vertex with lysis buffer 10 min,increase lysis buffer to
1000 ul
Vertex with lysis buffer 10 min,increase lysis buffer to
1000 ul
Vertex with lysis buffer 10 min,increase lysis buffer to
1000 ul
Vertex with lysis buffer 10 min,increase lysis buffer to
1000 ul
Vertex with lysis buffer 10 min,increase lysis buffer to
1000 ul
Vertex with lysis buffer 10 min,increase lysis buffer to
1000 ul
Vertex with lysis buffer 10 min,increase lysis buffer to
1000 ul
Vertex with lysis buffer 10 min,increase lysis buffer to
1000 ul

1200 ul binding solution as protocal
increased DNA binding solution to
1575 ul
increased DNA binding solution to
1800 ul
increased DNA binding solution to
1800 ul
increased DNA binding solution to
1800 ul
increased DNA binding solution to
1800 ul
increased DNA binding solution to
1800 ul

13
14
15
16
17
18
19
20
21
22
23

adding ,increased binding time to 5 min
adding ,increased binding time to 5 min
adding ,increased binding time to 5 min
adding ,increased binding time to 5 min
adding ,increased binding time to 5 min
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Procedure adjustment (continue)
Sample
DNA Elution improvement
1
as protocol
2
as protocol
3
as protocol
4
repeated the last step by put the elute in the IV-HRC spin filter twice
5
repeated the last step by put the elute in the IV-HRC spin filter twice
6
repeated the last step by put the elute in the IV-HRC spin filter twice
7
repeated the last step by put the elute in the IV-HRC spin filter twice
8
repeated the last step by put the elute in the IV-HRC spin filter twice
9
adding,increased of 100 ul elution buffer to elude the DNA in final step
10
adding, increased of 50 ul elution buffer to elude the DNA in final step
11
adding, increased of 50 ul elution buffer to elude the DNA in final step
12
adding, increased of 50 ul elution buffer to elude the DNA in final step
13
adding, increased of 50 ul elution buffer to elude the DNA in final step
14
adding, increased of 50 ul elution buffer to elude the DNA in final step
15
adding,washed the 1x column with 400 ul with nuclease-free water
16
adding,washed the column with elute buffer twice
17
adding,washed the 1x column with 400 ul with nuclease-free water
adding,washed the 1x column with 400 ul with nuclease-free water
18
twice
19
adding,diluted elute solution 1:10 with TE buffer
20
adding,diluted elute solution 1:10 with TE buffer
21
adding,diluted elute solution 1:10 with TE buffer
22
adding,diluted elute solution 1:10 with TE buffer
23
adding,diluted elute solution 1:10 with TE buffer
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Results
Sample
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23

Concentration (ng/ul)
97.37
92.28
71.96
74.27
120.11
104.18
123.22
115.94
53.59
175.00
57.76
58.74
99.01
68.77
155.98
101.46
44.74
141.42
117.61
170.87
48.75
68.1
35.35

260/280 Ratio
1.36
1.45
1.47
1.52
1.33
1.48
1.54
1.53
1.26
1.58
1.52
1.41
1.60
1.47
1.80*
0.93
1.58
1.82*
1.83*
1.85*
1.78
1.77
1.72

59

DNA Concentration (ng/ul)
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Figure 10.1 DNA Concentration detected by Nanodrop Spectrophotometer.
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Figure 10.2 DNA Quality detected by Nanodrop Spectrophotometer
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Table 3. The DNAzol Direct Extraction Method
Procedure adjustment

Sample
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
29

weight (mg)
5.7
4.3
4.1
2.9
1.8
1.4
5.9
4.7
2.1
4.8
4.4
3.6
5.0
5.4
4.9
5.0
4.8
2.6
4.8
4.6
2.9
3.1
4.8
10.0
12.6
touch with
pipette tip
touch with
pipette tip
touch with
pipette tip

incubation
temperature (C °)
85
85
85
85
85
85
85
85
85
room temperature
room temperature
room temperature
90
90
90
90
95
95
95
95
95
95
95
95
95

Vertex time
(sec)
briefly
briefly
briefly
10
10
30
30
30
30
30
30
30
10
30
10
30
30
30
30
30
30
30
briefly
briefly
briefly

95

briefly

95

briefly

95

briefly

note: Sample 21-24 were centrifuged at 32000 rpm after vertex

61

PCR Results
Sample
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
29

amplified with g-bifid primer
no
no
no
no
no
no
no
show but wrong size
show but wrong size
no
show but wrong size
no
show but wrong size
show but wrong size
show multiple bands
show multiple bands
show multiple bands
show multiple bands
no
show
show multiple bands
show multiple bands
no
show multiple bands
show multiple bands
show but wrong size
show but wrong size
show but wrong size

amplified with BiBre primer
n/a
n/a
n/a
no
no
no
no
no
no
no
no
no
no
no
no
no
no
smear
n/a
yes
smear
show multiple bands
no
no
n/a
n/a
n/a
n/a
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Table 4. Results of PCR for amplification of Lacto, Bifid1, Bifid2, and
BiBre primer

Template DNA souce
Fresh collected feces
Fresh frozen feces
ATCC dry cell + Feces
ATCC live cell + Feces
Feces collected directly from colon incision
mouse colon mucosa
Whole colon

Primer
Lacto Bifid1 Bifid2 BiBre

+
+
N/A
N/A

+
-

+
+
-

+
+
+
+
-

+
+
-
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Lactic acid bacteria (LAB) and Bifidobacterium are the most common types of
microbes used as probiotics. They are present in the human gastrointestinal tract
and have a significant influence on our health and well-being. Microbiota plays an
important role in host metabolism and provides a natural defense mechanism
against invading pathogens. This experiment was focusing on establish a method to
detect the gastrointestinal tract microbiota, either by fecal or colonic tissue DNA
extraction.
The experiment comparing 2 types of DNA extraction; ZR Fecal kit and
DNAzol direct. DNAzol direct was easy to use but was not suitable for long term
DNA storage, hence the sample need to be extract fresh when needed. The
extracted DNA, when amplified with Lacto genus specific primer show 99% match
with sequence of Lactobacillus reuteri in database. For primer sensitivity test, Bifid1
genus specific primer could detect DNA up to a dilution of 10-10, or approximately 10
ag of DNA. For species specific primers, BIA could detect DNA up to a dilution of 108,

or 1 fg of DNA. Both BiLon and BiBre primer could detect DNA up to a dilution of

10-7, or 10 fg of DNA. The PCR product of Bifid1 primer amplified against ATCC

74
bacteria DNA:-resulted in 99% match with all 3 bacteria sequences (B. breve, B.
Adolescentis, and B. Longum). When using BiBre and BIA primers amplified against
B. breve and B. infantis ATCC DNA, the sequences were 100% similar to each
species in bacteria database. For BiLon primer, the results yield 96% match.
The difference in age of the mice could play an important role in the presence
of bacteria detected in fecal samples, due to unequally delayed development of the
young mice’s intestinal ecosystems. The presence of bacteria in feces might not
represent the type or quantity of bacteria that inhabitant the colon. One challenge
that needs to be overcome in recovery of DNA is finding the lyses method that could
penetrate peptidoglycan, the heavily cross-linked structure in gram-positive bacteria
cell wall. Also find the method to verify the development of the pathophysiological
changes, that are claimed to be responsible for the variation in bacterial levels in the
GI tracts of the mice, would make the results more accurate. Further large-scale
research in animals and humans, especially randomized controlled trials, is
warranted.
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